Printer Friendly

Articles from M2 Pharma (September 25, 2017)

1-22 out of 22 article(s)
Title Author Type Words
5G, artificial intelligence and support for SMEs lead topics at opening of global ITU Telecom World 2017 conference; Innovative partnerships set to emerge from telecom networking and exhibition event ITU Telecom World. Conference news 1288
Abbott awarded US FDA approval for MRI-Compatibile Ellipse ICD for treating arrhythmias and other cardiac conditions. 341
AbbVie, Bristol-Myers Squibb Partner to Evaluate Combination of Antibody Drug Conjugate and Opdivo in Non-small Cell Lung Cancer. 332
Athletico Physical Therapy closes The Work Center acquisition. 166
Bayer names Sharon James as head of Global Innovation & Development for Consumer Health. 154
Correction - The European Commission approves Novartis' Rydapt for blood disorders. Correction notice 256
DelMar Pharmaceuticals Closes USD 10m Registered Direct Offering. 321
Eleven Biotherapeutics Redirects Resources to Completion of Phase 3 Trial. 396
European Commission grants approval to Merck and Pfizer for Bavencio. 197
FDA Approves Bristol-Myers Squibb's Opdivo (nivolumab) for Treatment of Hepatocellular Carcinoma in Patients Previously Treated with Sorafenib. 320
FDA Approves Use of Agilent Pharmdx Companion Diagnostic in Gastric or GEJ Cancer. 327
FURLEY PAGE LAWYERS ARE RECOGNISED FOR PROVIDING A "WORLD CLASS" SERVICE TO WEALTHY CLIENTS. 635
Global Contract Pharmaceutical Manufacturing Market to Reach USD 94.6bn by 2022, Research and Markets Forecasts. 375
In advance of World Tourism Day, ICAO and major aviation groups launch new joint report on economic benefits of air transport. 697
Kalorama: Immunoassays Show Strength, Especially in Three Areas. 724
Magellan Health Raises USD 394.7m from Sale of Senior Notes, Refinances of Senior Credit Facility. 300
Merck Receives FDA Approval for Keytruda (pembrolizumab) for Progressive Gastric or GEJ Cancer Expressing PD-L1. 463
Moberg Pharma adds TorbjA[pilcrow sign]rn Warnheim to management team. 125
Qfix unveils new SDX 3.0 Respiratory Gating System for improvement in the irradiation of tumor sites affected by respiratory motion. 323
The European Commission approves Roche's Gazyvaro in combination with chemotherapy. 151
The NDA Group names new director. 149
TherapeuticsMD Will Move to NASDAQ Global Select Market. 260

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters